PT975761E - Interferao beta humano recombinante com solubilidade melhorada - Google Patents

Interferao beta humano recombinante com solubilidade melhorada

Info

Publication number
PT975761E
PT975761E PT98920533T PT98920533T PT975761E PT 975761 E PT975761 E PT 975761E PT 98920533 T PT98920533 T PT 98920533T PT 98920533 T PT98920533 T PT 98920533T PT 975761 E PT975761 E PT 975761E
Authority
PT
Portugal
Prior art keywords
phe
leu
recombinant human
human beta
improved solubility
Prior art date
Application number
PT98920533T
Other languages
English (en)
Inventor
Gero Waschutza
Bernd Otto
Christian Schneider-Fresenius
Original Assignee
Fraunhofer Ges Zur For Der Ang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Zur For Der Ang filed Critical Fraunhofer Ges Zur For Der Ang
Publication of PT975761E publication Critical patent/PT975761E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT98920533T 1997-04-23 1998-04-16 Interferao beta humano recombinante com solubilidade melhorada PT975761E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19717864A DE19717864C2 (de) 1997-04-23 1997-04-23 Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung

Publications (1)

Publication Number Publication Date
PT975761E true PT975761E (pt) 2004-05-31

Family

ID=7827959

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98920533T PT975761E (pt) 1997-04-23 1998-04-16 Interferao beta humano recombinante com solubilidade melhorada

Country Status (10)

Country Link
US (3) US6572853B1 (pt)
EP (1) EP0975761B1 (pt)
JP (1) JP4189035B2 (pt)
AT (1) ATE257859T1 (pt)
CA (1) CA2287521C (pt)
DE (2) DE19717864C2 (pt)
DK (1) DK0975761T3 (pt)
ES (1) ES2214709T3 (pt)
PT (1) PT975761E (pt)
WO (1) WO1998048018A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19717864C2 (de) * 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6514729B1 (en) 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US6531122B1 (en) 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
US7431921B2 (en) 1999-08-27 2008-10-07 Maxygen Aps Interferon beta-like molecules
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
EP2080771A3 (en) 2001-02-27 2010-01-06 Maxygen Aps New interferon beta-like molecules
AU2003254641A1 (en) * 2002-08-28 2004-03-19 Maxygen Aps Interferon beta-like molecules for treatment of cancer
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
AU2003277088A1 (en) * 2002-10-01 2004-04-23 Xencor, Inc Interferon variants with improved properties
WO2005003157A2 (en) * 2003-06-10 2005-01-13 Xencor, Inc. Interferon variants with improved properties
EP2327724A3 (en) 2004-02-02 2011-07-27 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
KR100781666B1 (ko) 2004-11-02 2007-12-03 신영기 인간 인터페론-베타 변이체
US20080038224A1 (en) * 2006-03-28 2008-02-14 Thierry Guyon Modified interferon-beta (IFN-beta) polypeptides
EP2444499A3 (en) * 2006-05-02 2012-05-09 Allozyne, Inc. Amino acid substituted molecules
MX2009011870A (es) 2007-05-02 2009-11-12 Ambrx Inc Polipeptidos de interferon beta modificados y usos de los mismos.
NZ586947A (en) 2008-02-08 2012-11-30 Ambrx Inc Modified leptin polypeptides and their uses
DE102008051574A1 (de) 2008-10-14 2010-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Interferon-beta und deren Varianten
EP2431051A1 (en) * 2010-09-15 2012-03-21 Vakzine Projekt Management GmbH Type-1 interferons for the treatment of multiple sclerosis
JP6153470B2 (ja) 2011-10-01 2017-06-28 株式会社糖鎖工学研究所 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物
ES2687801T3 (es) 2013-03-29 2018-10-29 Glytech, Inc. Polipéptido presentando cadenas de azúcares sialiladas unidas al mismo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
DE19717864C2 (de) * 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
US6572853B1 (en) 2003-06-03
EP0975761B1 (de) 2004-01-14
JP4189035B2 (ja) 2008-12-03
CA2287521A1 (en) 1998-10-29
EP0975761A1 (de) 2000-02-02
DK0975761T3 (da) 2004-02-16
DE59810596D1 (de) 2004-02-19
CA2287521C (en) 2009-08-11
DE19717864C2 (de) 2001-05-17
DE19717864A1 (de) 1998-10-29
WO1998048018A1 (de) 1998-10-29
US20060093579A1 (en) 2006-05-04
US20040022763A1 (en) 2004-02-05
ES2214709T3 (es) 2004-09-16
JP2001523957A (ja) 2001-11-27
ATE257859T1 (de) 2004-01-15
US7052687B2 (en) 2006-05-30
US7575894B2 (en) 2009-08-18

Similar Documents

Publication Publication Date Title
PT975761E (pt) Interferao beta humano recombinante com solubilidade melhorada
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
ES8601858A1 (es) Homologos de la aprotinina
ATE9595T1 (de) Verfahren zur enzymatischen herstellung von peptiden.
EP0307592A3 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
BG103335A (en) Application of fumaric acid derivatives
GR3006172T3 (pt)
HU9200548D0 (en) Improved activity process of recombined proteins
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
FI964186A0 (fi) Ei-liittävät gp350/220-variantit
IE830529L (en) Insulins from preproinsulins
ATE216234T1 (de) Zusammensetzungen aus aminosäure zur behandlung von infektionen
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
BR9306693A (pt) Processo para purificação de uma solução aquosa de enzima
IT8647912A0 (it) Procedimento enzimatico per preparare l'amminoacidi contenenti zolfo
DE3852105D1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
DE59606266D1 (de) Verbesserung der Verträglichkeit von pharmazeutisch wirksamen Beta-Aminosäuren
PT90739A (pt) Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
AU637589B2 (en) Ancrod proteins, their production and use